Articles On LBT Innovations (ASX:LBT)

  Clever Culture’s AI-enabled APAS Independence device automates the arduous process of agar plate reading at large drug facilities Having attracted Astrazeneca as a foundation client, the company is talking to at least 14 more Big Pharma...

Aroa says the real impact from the 10% US tariff imposed on New Zealand goods will be much less than that Quarter time scores show companies are kicking with the wind Dimerix shares enter trading halt ahead of licensing deal   Kiwi wounds...

Clever Culture Systems’ pivot to target big pharma customers is proving a success Company has landed deals with Astra Zeneca and Bristol Myers Squibb Reported maiden half-year profit after income tax of $1.1m in H1 FY25   Special Report...

Smaller ASX healthcare companies are buddying up with larger companies to spearhead growth Lumos Diagnostics partners with industry leaders to deliver point-of-care tests Wellnex has a global licencing agreement with one of the world’s lar...

ASX health stocks fell xx% over past week, while the broader market was up about % Australia’s biggest health care name CSL weighed on sector with soft H1 FY25 result Shares of merged Chemist Warehouse and Sigma Healthcare started trading...

From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose...

Sonic Healthcare to buy LADR – Laboratory Group Dr. Kramer & Colleagues in Germany for ~A$700 million ASX health stocks fall 2.3% over past five days, while the broader market fell ~1.5%  Chemist Warehouse could list on the ASX by earl...

Highlights Clever Culture Systems wins $3.1M AstraZeneca order for four APAS instruments.  Enhances environmental monitoring at global manufacturing sites.  Total commitment reaches nine instruments, worth up to $7.2M. Clever Cult...

Recently rebranded Clever Culture Systems (ASX: CC5) continues to see success with its strategy targeting the pharmaceutical environmental monitoring market, selling a further four of its APAS Independence instruments to multinational pharm...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

Among the many witticisms attributed to Albert Einstein: insanity is doing the same thing over and over and expecting different results. In the case of LBT Innovations (ASX:LBT), for years the company pursued a strategy of selling its autom...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

ASX health stocks fall 0.37% over past five days in line with broader markets  Cardiac company Imricor’s VISABL-AFL trial for US FDA starts in US LBT Innovations has secured a major deal with big pharma AstraZeneca Healthcare and life sci...

  Brent Barnes – CEO & Managing Director – LBT Innovations (ASX:LBT) provides intelligent automation solutions to microbiology laboratories.

The ASX200 made a small recovery today after the torrid start to the week, closing up a quarter of a per cent to about 7700 points. Real Estate made the biggest recovery, adding nearly 1.3%, followed by Utilities and Telecommunications –...

Medical tech company LBT Innovations Ltd (ASX:LBT) has seen its share price rise more than 33% on news of a deal worth up to $4.1 million which it has inked with multinational Astrazeneca for the supply and maintenance of its platform techn...

Australian medical technology company LBT Innovations (ASX: LBT) has signed a $4.1 million deal to supply its APAS (automated plate assessment system) Independence kits plus support and maintenance services to global biopharmaceutical compa...

  Arrow Minerals (ASX:AMD) announced an Exploration Target estimate for the Niagara Bauxite Project of approximately 170 – 340Mt. The mapped presence of host rocks (Mesozoic mafic intrusives) considered favourable for the formation of bauxi...

LBT Innovations Limited (ASX: LBT) shares are having a very strong session on Wednesday. At one stage today, the small cap ASX stock was up as much as 80% to 2.7 cents. It has since pulled back but remains up 40% to 2.1 cents at the time of...

The ASX200 is set to trade lower today with futures predicting a fall of 0.27% near 8.30am AEDT on Wednesday, as US markets began to recover from significant losses earlier in the week and European markets experienced a choppy night. US...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

ASX health stocks rise in past five days, despite May uptick in inflation  Healius downgrades guidance for FY24, citing inflationary pressures Immutep falls despite positive results from Phase 2 trial in first line head and neck cancer He...

ASX rises +0.5pc driven by tech, banking, and property sectors This comes as US Fed maintains rates, now plans only one cut in 2024 Aussie unemployment drops to 4pc in May, but analysts predict further rises   Aussie shares rose by +0.5%...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

This week’s Bulls N’ Bears top ASX runner is… Resource Mining Corporation. Its share price rose more than 213 per cent to join LBT Innovations, Task Group Holdings and Arafura Rare Earths.

LBT Innovations (ASX:LBT) has announced the successful completion of primary validation for the APAS PharmaQC product. The company is a leader in microbiology automation using artificial...

  Local markets give up early gains then regains them, closing 0.22pc higher Consumer Discretionary stocks offset losses in materials and Energy  Small Caps led by LBT Innovations   It’s hard to stay afloat when BHP sinks to a near nine-m...

LBT Innovations Limited (ASX: LBT) shares are catching the eye on Wednesday. At one stage today, the ASX AI healthcare stock was up as much as 170% to 3.8 cents. The medical technology company's shares have given back most of these gains s...

LBT Innovations (ASX: LBT) has announced that its APAS (Automated Plate Assessment System) PharmaQC technology for automated imaging, analysis and interpretation of microbiology culture plates is ready for sale to global markets. The announ...

13 Mar 2024 - A snapshot of the stocks on the move, featuring ABx Group (ASX:ABX), LBT Innovations (ASX:LBT) and NickelSearch (ASX:NIS).

  To register for Friday's webinar click here. ABx Group (ASX:ABX) announced high-grade rare-earth elements results from the recently completed 97-hole drilling campaign at Rubble Mound. The results enlarged the extent of the Rubble Mound h...

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

  Brent Barnes – CEO & Managing Director – LBT Innovations (ASX:LBT) is a groundbreaking designer of advanced technology solutions for the medical industry. 

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help...

  Local markets end flat like an old can of coke on the coffee table Sectors are mixed up. I’m mixed up after all that Small Caps led by Way2VAT again, as well as some cracking local medtechs   It is 4pm on Thursday February 22, and the S...

Cogstate falls 7pc as clinical trials pipeline declines LBT Innovations delivers its technology to Thermo Fisher   Cogstate down after pipeline contracts Neuroscience biotech, Cogstate (ASX:CGS), tumbled by as much as -10% this morning af...

22 Feb 2024 - A snapshot of the stocks on the move, featuring 88 Energy (ASX:88E, AIM:88E, OTC:EEENF), Auric Mining (ASX:AWJ) and LBT Innovations (ASX:LBT).

Australian medical technology company LBT Innovations (ASX:LBT) has announced the delivery of its APAS PharmaQC to Thermo Fisher Scientific.

The S&P ASX 200 rose 1.19% in January to finish at a record high Energy was the winner with a 5% gain due to the turnaround in oil prices Health stocks up in January, including Singular Health Group and PharmAust After some up days an...

This week’s Bulls N’ Bears profiled ASX runner is… Plenti Group. Its shares more than doubled this week to join fellow runners Intelicare, Euro Manganese and LBT Innovations.

The ASX benchmark has ended Wednesday higher after positive inflation data 7 of 11 sectors in the green, IT ahead by circa +2pc Small caps led by Euro Manganese The local market has trimmed the CPI fat of this morning’s gains, after the...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...